SCHEMBL175204

SCHEMBL175204

CC(C)(C)c1cc(C(=O)Nc2cccc3c2C(=O)c2ccccc2-3)n(Cc2ccccc2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 9/20 0.62
ALDH1A1 P00352 4/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
GRN P28799 3/20 0.57
SORT1 Q99523 3/20 0.57
GAA P10253 5/20 0.56
MAPT P10636 5/20 0.55
MAPK1 P28482 4/20 0.55
AGTR1 P30556 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
KCNH2 Q12809 1/20 0.55
CRHBP P24387 1/20 0.55
CRHR2 Q13324 1/20 0.55
HTR1E P28566 1/20 0.54
S1PR3 Q99500 1/20 0.54
RECQL P46063 1/20 0.49
NPC1 O15118 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145690 0.83 NPSR1 (0.72) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL1897745 0.82 NPSR1 (0.71) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL1898164 0.80 NPSR1 (0.89) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL148799 0.80 NPSR1 (0.67) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL144524 0.78 NPSR1 (0.70) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL1899459 0.77 NPSR1 (1.00) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL146787 0.76 NPSR1 (0.74) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL143529 0.76 NPSR1 (0.67) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL143851 0.76 NPSR1 (0.81) NPSR1ALDH1A1L3MBTL1GRNSORT1
SCHEMBL1899685 0.76 NPSR1 (0.85) NPSR1ALDH1A1L3MBTL1GRNSORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059047-A1 DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR VERVA PHARMACEUTICALS PTY LTD (AU) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059047-A1 DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR FGF1, FABP4, FGF2 NPSR1 3871/4885ALDH1A1 1103/4885L3MBTL1 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.